SCHEMBL23478014

SCHEMBL23478014

COC(=O)c1cccc(NSc2cc(F)ccc2F)c1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
KDM4E B2RXH2 6/20 0.42
ALDH1A1 P00352 2/20 0.42
HPGD P15428 2/20 0.42
SLC6A4 P31645 1/20 0.42
SLC6A3 Q01959 1/20 0.42
MAPT P10636 6/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
HTT P42858 1/20 0.40
PDK2 Q15119 1/20 0.40
POLB P06746 1/20 0.40
ATM Q13315 1/20 0.40
TDP1 Q9NUW8 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PRMT5 O14744 1/20 0.39
WDR77 Q9BQA1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23478071 0.84 SLC6A4 (0.38) TSHRCYP1A2CYP2D6CYP2C19ALDH1A1
SCHEMBL18616763 0.81 KDM4E (0.44) TSHRCYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL29721254 0.75 CYP3A4 (0.52) TSHRCYP2C19LMNASMN1; SMN2PKM
SCHEMBL29721313 0.75 CYP3A4 (0.52) TSHRCYP2C19LMNASMN1; SMN2PKM
SCHEMBL1127184 0.75 CYP3A4 (0.52) TSHRCYP2C19LMNASMN1; SMN2PKM
SCHEMBL18680990 0.75 ERN1 (0.38) KDM4EALDH1A1
SCHEMBL13824011 0.74 SLC6A3 (0.54) TSHRCYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL1804668 0.73 TSHR (0.52) TSHRCYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL1803598 0.73 KDM4E (0.68) TSHRCYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL1401560 0.72 TSHR (0.57) TSHRCYP1A2CYP2D6CYP2C19KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021110997-A1 N-(3-(5-(PYRIMIDIN-4-YL)THIAZOL-4-YL)PHENYL)SULFONAMIDE COMPOUNDS AND THEIR USES AS BRAF INHIBITORS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2021-06-10 WO disclosed